Sutro Biopharma (STRO) reported third-quarter 2026 revenue of $9.1 million and a net loss of $31.5 million, compared with revenue of $9.7 million and a net loss of $56.9 million a year earlier. Net loss per share was $1.90, versus $6.66 in the prior-year quarter.
The company ended September with $142.2 million in cash, cash equivalents and marketable securities and said its current operating plan is expected to support operations into the first half of 2028.
- R&D and G&A expenses totaled $31.0 million, compared with $48.6 million in the third quarter of 2025.
- STRO-004 dose optimization is continuing, with a clinical update and expansion cohorts planned for the first half of 2027.
- STRO-006 entered the clinic after the first patient was dosed in October; an initial update is expected in the second half of 2027.
- Astellas began dosing patients in a second dual-payload iADC program targeting B7-H3, triggering a $10 million milestone payment received in October.
$STRO Hedge Fund Activity
We have seen 63 institutional investors add shares of $STRO stock to their portfolio, and 37 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 889,971 shares (+382.5%) to their portfolio in Q2 2026, for an estimated $29,547,037
- SAMSARA BIOCAPITAL, LLC added 858,369 shares (+419.7%) to their portfolio in Q2 2026, for an estimated $28,497,850
- RA CAPITAL MANAGEMENT, L.P. removed 715,307 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $23,748,192
- PERCEPTIVE ADVISORS LLC added 589,539 shares (+82.4%) to their portfolio in Q2 2026, for an estimated $19,572,694
- POINT72 ASSET MANAGEMENT, L.P. removed 454,284 shares (-65.6%) from their portfolio in Q2 2026, for an estimated $15,082,228
- BALYASNY ASSET MANAGEMENT L.P. added 245,370 shares (+52.7%) to their portfolio in Q2 2026, for an estimated $8,146,284
- AMERIPRISE FINANCIAL INC added 244,669 shares (+inf%) to their portfolio in Q2 2026, for an estimated $8,123,010
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.